Investment | Superannuation | SMSF | SMA | MDA | SHARES
Privacy Policy · Disclaimer · FSG
F Palmer & ME Palmer
Trading as Joseph Palmer & Sons
AFS Licence 247067 · ABN 29 548 490 818

Philanthropy

“That’s what I consider true generosity. You give your all, and yet you always feel as if it costs you nothing.”

Simone de Beauvoir

Have you a desire to contribute to good causes?

Most Australians have a high ‘generosity of spirit’ when it comes to their philanthropic intentions and seek ways to give to those less fortunate than themselves.

That said, it is also true that those who have worked hard for their wealth want to make sure that the money they give will be dealt with efficiently and effectively on its journey to the intended destination.

We are fully aware of these facts at Joseph Palmer & Sons and we established the Joseph Palmer Foundation to cater for clients who wish to express their generosity in a simple and practical manner.

The benefits to those who have a passion to donate to charitable causes are as follows:

  • Joseph Palmer & Sons have been investing for clients since 1872.
  • We apply our history, experience and foresight to everything we do for clients.
  • The Joseph Palmer Foundation is an ideal investment vehicle for giving to your charity of choice.
  • The fund complies in every way with the strict laws that govern its activities.
  • Donations to the fund are tax deductible.

Contact Us

Full name*
Email*
Phone number*
Message*
.
Slide To Submit
»
Please fill out the form and slide to submit

Donation Form

Click here to download form (General Fund).

Click here to download form (Sub-Fund).

Media Articles

A Welcome Note of Thanks

Author: ITworx/Thursday, August 7, 2025/Categories: News

Rate this article:
5.0

The generous folk who have made philanthropic donations through the Joseph Palmer Foundation will be pleased to know that the board recently received a message from Professor Susan Clark of the Garvan Institute of Medical Research.

Professor Clark expressed sincere thanks on receiving the grant which will be used to further essential research of epigenetic therapies in the treatment of prostate cancer.

With this condition being a leading cause of cancer-related deaths, funding this research could be a game-changer in the fight against this devastating disease and will provide new hope for patients with advanced prostate cancer.

For your interest, we provide a link to the Garvan 2024 Annual Report here. Professor Susan Clark features on page 19 & 33, The Centre for Population Genomics on page 23 and the Translational Oncology Program on page 17.

The members of the board would like to acknowledge and sincerely thank the generous and purpose-driven contributors to the Joseph Palmer Foundation.

Print

Number of views (172)/Comments (0)